News releases

Unitaid launches US$28.6 million investment to integrate diagnostic services and expand access to care

New Unitaid-backed projects will support countries to develop and evaluate integrated diagnostic approaches that respond to people’s health needs, and expand access to testing for multiple diseases that improve links to care.

© Unitaid

Unitaid is investing US$28.6 million to expand access to testing for multiple diseases. Through two complementary projects led by the Aurum Institute and Benin’s National Tuberculosis Program, the investment will explore how countries can better connect diagnostic services, identify conditions that might otherwise go undetected and help more people get the tests and care they need.

The work will span countries across Africa and Asia and focus on diseases including tuberculosis (TB), HIV, the human papillomavirus (HPV) and other sexually transmitted infections (STIs). It will also explore how diagnostic platforms and services for these diseases can be used to expand access to testing for other conditions.

Today, health services, including testing, are often organized around single diseases. As a result, people may need to make repeated visits to health facilities, wait longer for a diagnosis or miss out on tests they need. The Lancet Commission on Diagnostics estimates that nearly half of the world’s population has little or no access to essential diagnostic services. This can delay treatment and contribute to the spread of disease.

The projects will explore how countries can connect services across diseases; for example, by offering additional relevant tests during a single health visit or sharing diagnostics platforms and sample referral networks. It will examine the full pathway from testing and diagnosis to referral and treatment, and generate evidence on when and where integrated approaches can benefit patients and health systems, what they cost and how countries can sustain them.

Too many people still struggle to get the tests they need. Expanding access to diagnostics is not just about having the right tests – it’s also about making smarter use of existing health systems to ensure people get the right test, at the right time and can be linked to timely care. Through this investment, Unitaid and partners will help countries identify where integrated approaches can make the greatest difference.

Janet Ginnard

Director of Strategy at Unitaid

Putting people’s health needs at the center

Multi-disease Integrated Diagnostics Access & Scale-up (MIDAS), a four-year project led by the Aurum Institute, will work with countries to identify gaps in access to testing and opportunities to better meet people’s needs.

The project will support governments in five countries  – India, Kenya, Mozambique, Viet Nam and Zambia – to identify priority gaps in diagnostic services and develop approaches tailored to national priorities and health-system realities. This includes assessing how routine visits to health facilities and community health services can create more opportunities to diagnose conditions that might otherwise go undetected and connect people to appropriate care.

The project will also engage South Africa and Cameroon through more focused activities to identify priorities for improving access to diagnosis. Across participating countries, MIDAS will assess benefits, costs and operational requirements to inform national decisions on sustainable expansion.

We have a tremendous opportunity now to ensure patient centered care by providing appropriate diagnostics with rapid treatment initiation for people who need it.

Salome Charalambous

Group Chief Health Officer at The Aurum Institute

Expanding access to molecular testing

In Benin, the National Tuberculosis Program will lead Pooled Optimization & Integrated Testing (POOL-IT), a project that will explore how pooled testing can expand access to molecular diagnostics and make testing for multiple diseases more affordable.

Pooled testing combines samples from several people for an initial test. The number of samples combined will depend on the disease and testing protocol, which this project will explore. In suitable settings, this approach can reduce the number of tests needed and lower costs, allowing existing diagnostic resources to reach more people. Research supported by Unitaid contributed to the evidence informing the World Health Organization (WHO) recommendation on pooled testing in resource-constrained settings earlier this year.

POOL-IT will evaluate this approach for diseases including HIV, TB, hepatitis B and C, HPV and STIs across five countries: Bangladesh, Benin, Cameroon, Nigeria and Rwanda. The project will assess accuracy, costs and feasibility of pooled testing and develop practical tools and policy guidance to help countries determine where it can effectively expand access to diagnosis.

Working with country, regional and global partners, POOL-IT will also support wider adoption of pooled testing to make better use of existing diagnostic capacity and extend access to testing for multiple diseases.

Innovation is not always about developing new technologies. Sometimes, it is about finding better ways to use what we already have. Through POOL-IT, we want to explore how pooled testing can make molecular diagnostics more affordable and accessible, particularly in settings where resources are limited and diagnostic needs remain high.

Prof. Dissou Affolabi

Director of Benin's National Tuberculosis Programme

Together, the projects will provide evidence, practical tools and implementation experience to help countries decide where integrated diagnostics and pooled testing can add value, what they require and how to finance and sustain them. The findings will also inform wider adoption beyond participating countries.


Notes to editors

About MIDAS:

Multi-disease Integrated Diagnostics Access & Scale-up (MIDAS) is a four-year initiative led by the Aurum Institute that aims to improve access to diagnostic services by helping countries identify gaps, develop and evaluate integrated approaches an generate evidence to guide sustainable implementation.

The project brings together country and technical partners including the International Union Against Tuberculosis and Lung Disease in India, KNCV in Viet Nam, Fundação Aurum in Mozambique, the Centre for Health Solutions in Kenya, Christian Health Association Zambia, Treatment Action Group and Heidelberg University Hospital.

About POOL-IT:

Pooled Optimization & Integrated Testing (POOL-IT) is a four-year project let by Benin’s National Tuberculosis Programme that aims to generate evidence on the use of pooled testing to expand access to molecular diagnostics for multiple diseases.

Country partners include icddr,b in Bangladesh, the Centre for Health Promotion and Research in Cameroon, Zankli Research Centre in Nigeria, the University of Rwanda and the Rwanda Biomedical Centre, alongside the Stop TB Partnership.

About Unitaid:

Unitaid saves lives by making new health products affordable and available in low- and middle-income countries. Collaborating with partners, Unitaid identifies innovative treatments, tackles market barriers, and quickly delivers solutions to those in need. Since 2006, Unitaid has unlocked over 150 health products, addressing HIV, TB, malaria, women’s and children’s health, and pandemic preparedness. Every year, these products benefit more than 390 million people. Unitaid is a hosted partnership of the World Health Organization. www.unitaid.org

About the Aurum Institute:

Aurum is an African health research and implementation organisation that works with governments, communities and partners to generate evidence and strengthen the systems that deliver healthcare. Aurum conducts clinical research, evaluates new medicines, vaccines and diagnostic technologies, supports countries to introduce evidence-based interventions, and strengthen health systems so that innovation reaches the people who need it most.

About Benin’s National Tuberculosis Program:

Benin’s National Tuberculosis Programme (NTP) coordinates tuberculosis prevention and control activities nationwide, including diagnosis, treatment and patient follow-up. Beyond its national mandate, the NTP plays a key role in regional tuberculosis control, hosting the Executive Secretary of the West and Central African Regional Network for Tuberculosis Control (WARN/CARN-TB). Through its Mycobacteriology Reference Laboratory (LRM) in Cotonou, which serves as a WHO Supranational Reference Laboratory (SRL), the programme provides technical assistance and quality management support to National Tuberculosis Reference Laboratories in 24 countries across West and Central Africa. The LRM/SRL is actively engaged in research aimed at improving tuberculosis diagnosis and treatment.

Media contacts: